Navigation Links
Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
Date:9/13/2007

stor-owned hospitals. Whether nonprofits justify their tax-exempt status depends on the definition of "community dividends," the author notes.

"Free-Standing Ambulatory Surgery Centers and Hospital Surgery Volume," by John Bian and Michael A. Morrisey -- This study found that from 1993 to 2001, the addition of one ambulatory surgery center (ASC) per 100,000 population in a metropolitan area was associated with 4.3 percent fewer hospital outpatient surgeries each year; ASCs had no effect on hospital inpatient procedures.

"Estimating Regression Standard Errors with Data from the Current Population Survey's Public Use File," by Michael Davern, Arthur Jones Jr., James Lepkowski, Gestur Davison, and Lynn A. Blewett -- This analysis evaluates three methods of estimating standard errors for use with the Current Population Survey's Annual Social and Economic Supplement.

"The McNerney Forum: Public Reporting and Pay-for-Performance: Safety-Net Hospital Executives' Concerns and Policy Suggestions," by L. Elizabeth Goldman, Stuart Henderson, Daniel P. Dohan, Jason A. Talavera, and R. Adams Dudley -- This article reports on interviews with California safety-net hospital (SNH) administrators, whose main concerns were that human and financial resource constraints impede the ability of SNHs to accurately measure their performance.

"The View from Here: Thoughts on Health Insurance Expansions and the Value of Coverage" -- INQUIRY's new editor, Alan Monheit, discusses the goals of improved health status and risk protection as they relate to expanding health insurance (Article available at http://www.inquiryjournalonline.org/pdfserv/i0046-9580-044-02-0133.pdf ).

Recent release of note: Alan C. Monheit to succeed Katherine Swartz as INQUIRY editor -- Alan C. Monheit has been named the new editor of the health policy journal INQUIRY, succeeding Katherine Swart
'/>"/>

SOURCE INQUIRY journal
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. House heads for Medicare drug vote
3. New Medicare Plan - Mixed Reaction among Pharmacists.
4. Medicare Data would help in Drug Validation
5. Medicare Queries Expected To Increase Over Time
6. Medicare to cover services provided by rural health care personnels.
7. Cancer test expenses taken up by Medicare
8. Nurse Practitioners Are Not Recognized By Medicare
9. Medicare Drug Plan Is Not Working in The US
10. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
11. Rising Medicare costs
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 2Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 3Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 2Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 3Health News:Coffee, Exercise Fight Prostate Cancer 2Health News:Coffee, Exercise Fight Prostate Cancer 3
Other Medicine News:Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 2Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 3Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 4Health News:University Hospitals in Cleveland Selects Solution Suite from Agilysys 2Health News:University Hospitals in Cleveland Selects Solution Suite from Agilysys 3Health News:University Hospitals in Cleveland Selects Solution Suite from Agilysys 4Health News:CSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to Climb 2Health News:CSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to Climb 3Health News:Haemacure's Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury 2Health News:Haemacure's Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury 3Health News:Senior Housing and Services Provider Ecumen Welcomes Jim Klobuchar to Its Changing Aging Blog 2Health News:Senior Housing and Services Provider Ecumen Welcomes Jim Klobuchar to Its Changing Aging Blog 3Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 2Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 3
Breaking Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 1First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 2First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 3Teamsters Oppose Senate Plan to Tax Health Insurance Companies 61750 1Monogram Energy Inc Acquires Triad Therapeutics Inc 61747 1Monogram Energy Inc Acquires Triad Therapeutics Inc 61747 2